Evidence map›Paper›PMID 40998942›Full record

ArticleScientific reports2025

Ciprofloxacin pre-exposure influences individual cell MIC and heteroresistance of bacteria inside microfluidic droplets.

Shakeel Ahmad, Ilona P Foik, Paweł Jankowski, Adam Samborski, Shreyas K Vasantham, Piotr Garstecki

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shakeel AhmadInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Ilona P FoikInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland. ifoik@ichf.edu.pl.
Paweł JankowskiInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Adam SamborskiInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Shreyas K VasanthamInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
Piotr GarsteckiInstitute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland. pgarstecki@ichf.edu.pl.

Funding

European Union's Horizon 2020 program under the Marie Skłodowska-Curie (Grant no. 847413) 5005/H2020-MSCA-COFUND/2019/2The FNP TEAM-NET POIR.04.04.00-00-16ED/18-00The National Science Centre, Poland 2018/30/A/ST4/00036, Maestro 10
6 · The paper itself

Abstract

Bacterial cells in general present different phenotypes even within the monoclonal populations. Some phenotypes may offer selective advantages under antibiotic stress. In clinical practice such advantage may lead to selection of resistant phenotypes and to treatment failure. Improving treatment regimens thus requires thorough understanding of the underlying cause of developing phenotypic variations within bacterial populations exposed to antibiotics. Here, we use droplet microfluidics to study the response of individual bacterial cells. We investigate how a short-term exposure of ciprofloxacin or streptomycin at the sub-minimum inhibitory concentration levels changes the single-cell distribution of susceptibility on subsequent exposure to either of the antibiotics. We used three different concentrations of pre-exposure for each antibiotic on Escherichia coli MG1655 and followed with re-exposure of the same bacterial cells individually in microfluidic droplets. Experiments with various concentrations of re-exposure on single cells showed that pre-exposures to sub-lethal levels of ciprofloxacin can elevate the individual cell MIC and the level of heteroresistance to ciprofloxacin. Exposure to quarter and half MIC of ciprofloxacin in separate experiments increased the heteroresistance of pre-exposed cells by more than 20-fold on subsequent treatment with ciprofloxacin. Interestingly, the same ciprofloxacin pre-exposure pattern made the cells more fragile and, in some cases, decreased the individual MIC values to streptomycin. The results in our study can be very important in developing new better treatment regimen, addressing the wider problem of antibiotic resistance.

Indexed as

Anti-Bacterial AgentsCiprofloxacinDrug Resistance, BacterialEscherichia coliMicrofluidicsMicrobial Sensitivity TestsStreptomycinAnti-Bacterial AgentsCiprofloxacinStreptomycin

Identifiers

PMID40998942
PMCPMC12464320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.